ResMed to Announce Third Quarter Fiscal Year 2017 Results

SAN DIEGO, March 30, 2017 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced it will report its third quarter of fiscal year 2017 results on Thursday, April 27, 2017 after the New York Stock Exchange market closes. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a webcast to discuss operating results and future outlook.

The earnings webcast is scheduled to begin at 1:30 p.m. US Pacific Time and the live webcast of the call can be accessed on ResMed's Investor Relations website at investor.resmed.com. Please go to this section of the website and click on the icon for the "Q3 2017 earnings webcast."

Please note that we do not use outside phone lines to access the earnings call.

International earnings webcast times will be:


9:30 p.m.

London


6:30 a.m.

Sydney, Australia (April 28, 2017)




A replay of the earnings webcast will be accessible on our website and available approximately two hours after the webcast.  In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from April 27, 2017 until May 11, 2017 at:

US:

800-585-8367

Outside US:

+1 416-621-4642

Passcode:  98293201






About ResMed
ResMed (NYSE:RMD) changes lives with award-winning medical devices and cutting-edge cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with more than 2 million patients remotely monitored every day. Our 5,000-strong team is committed to creating the world's best tech-driven medical device company – improving quality of life, reducing the impact of chronic disease, and saving healthcare costs in more than 100 countries.
ResMed.comFacebookTwitter | LinkedIn

ResMed Inc. logo.

 

ResMed Contacts:


For News Media

For Investors

Alison Graves

Agnes Lee

Director, Global Corporate Communications

Vice President, Investor Relations and

O:858-836-6789

Corporate Communications

news@resmed.com

investorrelations@resmed.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/resmed-to-announce-third-quarter-fiscal-year-2017-results-300431643.html

SOURCE ResMed Inc.